Axsome Therapeutics, Inc. · NASDAQ:AXSM
Saad Mark E exercised options for 1,429 Axsome Therapeutics, Inc. shares (Form 4)
Traded Jun 8, 2026 · Filed Jun 10, 2026
On Jun 8, 2026, Saad Mark E (Director) exercised options for 1,429 Axsome Therapeutics, Inc. shares, leaving 11,431 shares. Filed Jun 10, 2026 (Form 4).
- Options exercised
- 1,429 shares
- Holding after
- 11,431 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | Option exercise | 1,429 | 11,431 | Direct |